- Topic
25k Popularity
2k Popularity
8k Popularity
15k Popularity
5k Popularity
2k Popularity
111k Popularity
27k Popularity
26k Popularity
18k Popularity
- Pin
- 🚨 Gate Alpha Ambassador Recruitment is Now Open!
📣 We’re looking for passionate Web3 creators and community promoters
🚀 Join us as a Gate Alpha Ambassador to help build our brand and promote high-potential early-stage on-chain assets
🎁 Earn up to 100U per task
💰 Top contributors can earn up to 1000U per month
🛠 Flexible collaboration with full support
Apply now 👉 https://www.gate.com/questionnaire/6888
- 🔥 Gate Square #Gate Alpha Third Points Carnival# Trading Sharing Event - 5 Days Left!
Share Alpha trading screenshots with #Gate Alpha Trading Share# to split $100!
🎁 10 lucky users * 10 USDT each
📅 July 4, 4:00 – July 20, 16:00 UTC+8
Gate Alpha 3rd Points Carnival Issue 10 is in full swing!
Trade and post for double the chances to win!
Learn more: https://www.gate.com/campaigns/1522alpha?pid=KOL&ch=5J261cdf
- 📢 Gate has released its latest Proof of Reserves report!
As of July 11, 2025:
💰 Total reserves reached $10.504 billion
📈 Reserve ratio stands at 126.03%
✅ Covers over 350 types of user assets
🔼 Surplus reserves increased 10.66% to $2.17 billion
Committed to transparency and user fund security.
📎 Learn more: https://www.gate.com/proof-of-reserves
- 📢 Gate Square #Creator Campaign Phase 1# is now live – support the launch of the PUMP token sale!
The viral Solana-based project Pump.Fun ($PUMP) is now live on Gate for public sale!
Join the Gate Square Creator Campaign, unleash your content power, and earn rewards!
📅 Campaign Period: July 11, 18:00 – July 15, 22:00 (UTC+8)
🎁 Total Prize Pool: $500 token rewards
✅ Event 1: Create & Post – Win Content Rewards
📅 Timeframe: July 12, 22:00 – July 15, 22:00 (UTC+8)
📌 How to Join:
Post original content about the PUMP project on Gate Square:
Minimum 100 words
Include hashtags: #Creator Campaign
- 🎉 [Gate 30 Million Milestone] Share Your Gate Moment & Win Exclusive Gifts!
Gate has surpassed 30M users worldwide — not just a number, but a journey we've built together.
Remember the thrill of opening your first account, or the Gate merch that’s been part of your daily life?
📸 Join the #MyGateMoment# campaign!
Share your story on Gate Square, and embrace the next 30 million together!
✅ How to Participate:
1️⃣ Post a photo or video with Gate elements
2️⃣ Add #MyGateMoment# and share your story, wishes, or thoughts
3️⃣ Share your post on Twitter (X) — top 10 views will get extra rewards!
👉
A drug from AstraZeneca failed to meet the primary goals of the study.
Jin10 reported on July 16 that AstraZeneca said on Wednesday that its experimental drug Anselamimab did not meet the primary endpoint of late-stage studies for the treatment of AL amyloidosis. AL amyloidosis is a rare disease that causes an increase in protein deposits in the body, leading to significant organ damage.